{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:15:18Z","timestamp":1792995318713,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi241041-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>With the advancement in administrative data as a research tool and the reliance on public health insurance for individuals with Down syndrome, population-level trends in Alzheimer dementia in this population are beginning to be understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241041-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To comprehensively describe the epidemiology of Alzheimer dementia in adults with Down syndrome in a full US Medicare and Medicaid sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241041-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      This cohort study included 132\u202f720 adults aged 18 years or older with Medicaid and\/or Medicare claims data with an\n                      <jats:italic>International Statistical Classification of Diseases and Related Health Problems<\/jats:italic>\n                      code for Down syndrome. Data were collected from January 1, 2011, to December 31, 2019, and analyzed from August 2023 to May 2024.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241041-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The main outcome was prevalence of Alzheimer dementia in each calendar year and during the 9-year period. Alzheimer dementia incidence rates by calendar year and age and stratified for race or ethnicity as well as time to death after Alzheimer dementia diagnosis were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241041-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 132\u202f720 unique adults with Down syndrome from 2011 to 2019: 79\u202f578 (53.2%) were male, 17\u202f090 (11.7%) were non-Hispanic Black, 20\u202f777 (15.7%) were Hispanic, 101\u202f120 (68.8%) were non-Hispanic White, and 47\u202f692 (23.3%) had ever had an Alzheimer dementia diagnosis. Incidence was 22.4 cases per 1000 person-years. The probability of an incident Alzheimer dementia diagnosis over 8 years was 0.63 (95% CI, 0.62-0.64) for those entering the study between ages 55 to 64 years. Mean (SD) age at incident diagnosis was 54.5 (7.4) years and median (IQR) age was 54.6 (9.3) years. Mean (SD) age at death among those with Alzheimer dementia was 59.2 (6.9) years (median [IQR], 59.0 [8.0] years). The mean (SD) age at onset for the Hispanic group was 54.2 (9.2) years, 52.4 (7.8) years for the American Indian or Alaska Native group, and 52.8 (8.2) years for the mixed race groups compared with 55.0 (7.8) years for the White non-Hispanic group. For age at death, there were no differences by sex. The mean (SD) age at death was later for the White non-Hispanic group (59.3 [6.8] years) compared with the Hispanic group (58.5 [7.8] years), Native American group (57.8 [7.1] years), and mixed race group (58.2 [7.0] years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241041-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of adults with Down syndrome who were enrolled in Medicaid and Medicare, Alzheimer dementia occurred at high rates. Consistency with clinical studies of dementia in Down syndrome supports the use of administrative data in Down syndrome\u2013Alzheimer dementia research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.35018","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T11:32:37Z","timestamp":1727091157000},"page":"e2435018","source":"Crossref","is-referenced-by-count":42,"title":["Alzheimer Dementia Among Individuals With Down Syndrome"],"prefix":"10.1001","volume":"7","author":[{"given":"Eric","family":"Rubenstein","sequence":"first","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salina","family":"Tewolde","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Michals","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Weuve","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Fox","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Pescador Jimenez","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Scott","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorghos","family":"Tripodis","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Skotko","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"issue":"24","key":"zoi241041r1","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down syndrome.","volume":"382","author":"Bull","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi241041r2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/maghis\/23.3.17","article-title":"Nothing about us without us: disability rights in America.","volume":"23","author":"Scotch","year":"2009","journal-title":"OAH Magazine History"},{"issue":"4","key":"zoi241041r3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","article-title":"Current estimate of Down Syndrome population prevalence in the United States.","volume":"163","author":"Presson","year":"2013","journal-title":"J Pediatr"},{"issue":"3","key":"zoi241041r4","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12472","article-title":"Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage.","volume":"15","author":"Haye","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6","key":"zoi241041r5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1474-4422(16)00063-6","article-title":"Dementia in Down\u2019s syndrome.","volume":"15","author":"Ballard","year":"2016","journal-title":"Lancet Neurol"},{"issue":"3","key":"zoi241041r6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mrdd.20163","article-title":"Alzheimer\u2019s disease in Down syndrome: neurobiology and risk.","volume":"13","author":"Zigman","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"4","key":"zoi241041r7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/1475-6773.13937","article-title":"A national assessment of legacy versus new generation Medicaid data.","volume":"57","author":"Nguyen","year":"2022","journal-title":"Health Serv Res"},{"issue":"8","key":"zoi241041r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.2320","article-title":"Medicaid enrollment and service use among adults with Down syndrome.","volume":"4","author":"Rubenstein","year":"2023","journal-title":"JAMA Health Forum"},{"issue":"2","key":"zoi241041r9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1001\/jamaneurol.2019.3666","article-title":"Epidemiology of dementia and Alzheimer disease in individuals with down syndrome.","volume":"77","author":"Rubenstein","year":"2020","journal-title":"JAMA Neurol"},{"issue":"14","key":"zoi241041r10","doi-asserted-by":"publisher","first-page":"8865","DOI":"10.3390\/ijerph19148865","article-title":"Examine race\/ethnicity disparities in perception, intention, and screening of dementia in a community setting: scoping review.","volume":"19","author":"Lee","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"zoi241041r12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JAD-181005","article-title":"Evaluation of Medicare claims data as a tool to identify dementia.","volume":"67","author":"Lee","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"zoi241041r13","first-page":"27","article-title":"More accurate racial and ethnic codes for Medicare administrative data.","volume":"29","author":"Eicheldinger","year":"2008","journal-title":"Health Care Financ Rev"},{"issue":"3","key":"zoi241041r14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size-or why the P value is not enough.","volume":"4","author":"Sullivan","year":"2012","journal-title":"J Grad Med Educ"},{"issue":"3","key":"zoi241041r15","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.14287","article-title":"Medicare, Medicaid, and dual enrollment for adults with intellectual and developmental disabilities.","volume":"59","author":"Rubenstein","year":"2024","journal-title":"Health Serv Res"},{"issue":"4","key":"zoi241041r16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","article-title":"Estimation of the number of people with Down syndrome in the United States.","volume":"19","author":"de Graaf","year":"2017","journal-title":"Genetics in Med"},{"issue":"5","key":"zoi241041r17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.12910","article-title":"Association of Alzheimer disease with life expectancy in people with Down syndrome.","volume":"5","author":"Iulita","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi241041r18","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/jir.12390","article-title":"A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome.","volume":"61","author":"McCarron","year":"2017","journal-title":"J Intellect Disabil Res"},{"issue":"10242","key":"zoi241041r19","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer\u2019s disease in adults with Down syndrome: a cross-sectional study.","volume":"395","author":"Fortea","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"zoi241041r21","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","article-title":"Alzheimer\u2019s disease associated with Down syndrome: a genetic form of dementia.","volume":"20","author":"Fortea","year":"2021","journal-title":"Lancet Neurol"},{"issue":"12","key":"zoi241041r22","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1017\/S1041610219000152","article-title":"Survival and life-expectancy in a young-onset dementia cohort with six years of follow-up: the NeedYD-study.","volume":"31","author":"Gerritsen","year":"2019","journal-title":"Int Psychogeriatr"},{"key":"zoi241041r23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jpeds.2016.03.023","article-title":"Contributions to racial disparity in mortality among children with Down syndrome.","volume":"174","author":"Santoro","year":"2016","journal-title":"J Pediatr"},{"issue":"3","key":"zoi241041r24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/geronb\/gbaa083","article-title":"Sex, race, and age differences in prevalence of dementia in Medicare claims and survey data.","volume":"76","author":"Zhu","year":"2021","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"1","key":"zoi241041r25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jalz.2018.06.3063","article-title":"Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015-2060) in adults aged =65 years.","volume":"15","author":"Matthews","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"11","key":"zoi241041r26","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1111\/jgs.18078","article-title":"Time to dementia diagnosis by race: a retrospective cohort study.","volume":"70","author":"Davis","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"zoi241041r27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/jgs.15258","article-title":"Effect of area-level socioeconomic deprivation on risk of cognitive dysfunction in older adults.","volume":"66","author":"McCann","year":"2018","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"zoi241041r28","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12039","article-title":"The Area Deprivation Index: a novel tool for harmonizable risk assessment in Alzheimer\u2019s disease research.","volume":"6","author":"Zuelsdorff","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"zoi241041r29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3233\/JAD-2009-1099","article-title":"The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited.","volume":"17","author":"Taylor","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"zoi241041r30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/jgs.15638","article-title":"Misidentification of dementia in Medicare claims and related costs.","volume":"67","author":"Zhu","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"zoi241041r31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/WAD.0b013e31805c0835","article-title":"Impact of patient selection criteria on prevalence estimates and prevalence of diagnosed dementia in a Medicaid population.","volume":"21","author":"Bharmal","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3-4","key":"zoi241041r32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3233\/TRD-200090","article-title":"Opportunities, barriers, and recommendations in down syndrome research.","volume":"5","author":"Hendrix","year":"2021","journal-title":"Transl Sci Rare Dis"},{"issue":"5","key":"zoi241041r33","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1002\/alz.13778","article-title":"Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome.","volume":"20","author":"Hillerstrom","year":"2024","journal-title":"Alzheimers Dement"},{"key":"zoi241041r20","volume-title":"Modeling the Impact of Research Investment on Down Syndrome & Associated Alzheimer\u2019s Disease","author":"Weden","year":"2023"},{"key":"zoi241041r11","unstructured":"CMS Chronic Conditions Data Warehouse (CCW), CCW Condition Algorithm. 2021. Center for Medicare and Medicaid Services. Accessed August 15, 2024. https:\/\/www2.ccwdata.org\/web\/guest\/condition-categories"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2823874\/rubenstein_2024_oi_241041_1726259571.92408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T11:32:40Z","timestamp":1727091160000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2823874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.35018","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}